Health AI Central
Share:
Peer-Reviewed Publication
Front Med Technol2021;3705003.January 1, 2021Journal Article

Cerebral Aneurysm Occlusion at 12-Month Follow-Up After Flow-Diverter Treatment: Statistical Modeling for V&V With Real-World Data.

Ana Paula Narata1, Laura Obradó2, Raquel Kalé Moyano2, Juan M Macho3, Jordi Blasco3, Antonio López Rueda3, Luis San Roman3, Sebastian Remollo4, Claudia Marinelli5, Rosana Cepeda5, Héctor Fernández2, Ignacio Larrabide2,6
1CHRU Hôpitaux de Tours, Tours, France.
2Neurovascular Unit, Galgo Medical S. L., Barcelona, Spain.
3CDI, Hospital Clinic of Barcelona, Barcelona, Spain.
4Area de Neurociencias, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
5ECOSISTEMAS-CIC/UNICEN, Tandil, Argentina.
6Pladema-CONICET/UNICEN, Tandil, Argentina.
PubMed PMC DOI PDF

Abstract

Background: Flow-Diverter (FD) porosity has been pointed as a critical factor in the occlusion of cerebral aneurysms after treatment. Objective: Verification and Validation of computational models in terms of predictive capacity, relating FD porosity and occlusion after cerebral aneurysms treatment. Methods: Sixty-four aneurysms, with pre-treatment and follow-up images, were considered. Patient de…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.